IBIO

0.80010.11%
WD

William D. Clark

Independent Chairman

Mr. William D. Clark, also known as Chip, M.B.A., serves as Independent Director at Aldeyra Therapeutics, Inc. since April 2025. He was Entrepreneur in Residence of SR One Capital Management, LP. till 2024. He has been an Independent Director at iBio, Inc. since August 26, 2021 and serves as its Chairman since November 1, 2022. He served as Director, Chief Executive Officer and President at Genocea Biosciences, Inc. since February 2011 until 2022. He co-founded Vanda Pharmaceuticals, Inc. in 2004. Mr. Clark served as Chief Financial Officer of Cubist Pharmaceuticals, Inc. Mr. Clark served as the Chief Business Officer at Genocea Biosciences, Inc. from August 2010 to February 2011. Mr. Clark served as the Chief Business Officer, Senior Vice President and Secretary of Vanda Pharmaceuticals, Inc. from September 2004 to March 26, 2010, which he co-founded in 2004. He has biotechnology and pharmaceutical experience with a focus on commercialization, business development and venture capital financing. Prior to Vanda, Mr. Clark was a Principal of Care Capital LLC, Care Capital Investments II, L.P. and Care Capital Investments III, L.P. Prior to joining Care Capital, he served as an Associate Director of Business Development for SmithKline Beecham Seiyaku (now GlaxoSmithKline), the Japanese affiliate of SB. There, he led the effort to establish a health care information business in Japan. He also evaluated the scientific and commercial prospects and developed the marketing plans for drug candidates. He worked at GlaxoSmithKline plc in a variety of commercial and strategic roles. Before Japan, he worked for SB in London, evaluating corporate strategic initiatives and helping to direct senior management's long-range planning efforts. He served as Director at X4 Pharmaceuticals, Inc. He served as a Director of Vanda Pharmaceuticals, Inc. from 2003 to 2004. He has experience as a founder and senior executive officer of other biopharmaceutical companies, as well as has prior public company board service. Mr. Clark received a B.A. from Harvard University and an MBA from The Wharton School, University of Pennsylvania. He had been a Director of Arsanis, Inc. since September 2017.

Positions